+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Intracarotid glucose induced norepinephrine response and the development of diet induced obesity

International Journal of Obesity and Related Metabolic Disorders 16(6): 451-457
Intracarotid glucose induced norepinephrine response and the development of diet induced obesity
Intracarotid glucose infusions cause increased plasma norepinephrine (NE) levels in some rats. This is used as an index of sympathetic activation. Similar increase in plasma NE levels are produced by intravenous glucose injections and these levels correlate positively with the amount of weight gained by adult rats when they are subsequently fed a diet enriched in calories, sucrose and fat (condensed milk (CM) diet) for three months. Thus, rats prone to develop diet induced obesity (DIO) on the CM diet have greater intravenous glucose induced NE responses than those which are diet resistant (DR). To test the hypothesis that this relationship is mediated by the brain, 17 chow fed, adult male Sprague-Dawley rats were infused for 60 min with intracarotid glucose at 4mg/kg/min and blood samples were obtained for plasma catecholamines, insulin and glucose. They were then placed on the CM diet for three months. After three months on the CM diet, there was a wide variability in body weight gain and the weights of retroperitoneal fat pads, an indirect measure of carcass adiposity. For all 17 rats, there was a significant correlation between both body weight gain (r=0.685, P=0.002) and retroperitoneal fat pad weights (r=0.590, P=0.013) with the levels of plasma NE reached 45-60min into the preceding intracarotid glucose infusions. For the six lowest and six highest glucose induced NE responders, the correlation between NE response and body weight gain on CM diet was r=0.944 (P=0.0001). Plasma epinephrine, insulin and glucose levels were unchanged during such infusions. Thus, glucose, acting directly on the brain, activates the sympathetic nervous system in those rats most likely to develop DIO on the CM diet. This suggests that responsiveness of the brain to glucose plays an important role in the differential body weight gain of rats exposed to diets high in calories, sucrose anf fat.

Accession: 002416085

PMID: 1322871

Related references

Differential colonization with Segmented Filamentous Bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice Microbiome variation and diet-induced obesity. 2013

The development of diet-induced obesity and glucose intolerance in C57BL/6 mice on a high-fat diet consists of distinct phases. Plos One 9(8): E106159-E106159, 2015

Selective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant. Journal of Diabetes Investigation 3(3): 245-251, 2012

Differential development of glucose intolerance and pancreatic islet adaptation in multiple diet induced obesity models. Nutrients 4(10): 1367-1381, 2013

Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity. International Journal of Obesity and Related Metabolic Disorders 17(2): 103-108, 1993

Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. American Journal of Physiology. Endocrinology and Metabolism 292(4): E1079-E1086, 2006

Glucose-induced norepinephrine levels and obesity resistance. American Journal of Physiology 253(3 Pt 2): R475-R481, 1987

Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice. Food & Function 5(7): 1452-1463, 2015

A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation. Biochemical Pharmacology 93(4): 482-495, 2015

Glucose induced norepinephrine levels and prediction of obesity resistance. Federation Proceedings 46(3): 881, 1987